Prosthetic-joint Infection: Clinical Trials

2 trials for Prosthetic-joint Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow Prosthetic-joint Infection: new trials by email Literature Review of Prosthetic-joint Infection trials Research Report on Prosthetic-joint Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
PLG0206, Placebo - Prosthetic-joint Infection
Phase 2 / Phase 3RecruitingPeptilogics2402026-02-032026-11-16
A Second Trial of the Abbreviated Protocol Two-Stage Exchange
VT-X7 Treatment System, Two-stage exchange arthroplasty, SOC Antibiotics - Prosthetic-joint Infection
Phase 2CompletedOsteal Therapeutics, Inc.762023-01-232025-01-07

Interventions

Sodium Chloride (1)

Sponsors

Osteal Therapeutics, Inc. (1)  ·  Peptilogics (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Nicolas Piuzzi, MD (1)